Pleiotropic cellular and tissue-level targets via secreted factors

The term "Pleiotropic cellular and tissue-level targets via secreted factors" refers to a descriptive classification used for complex biological therapeutics, such as mesenchymal stem cells (MSCs) and their derived secretomes, that lack a single discrete molecular target. Instead of binding to a solitary receptor, these therapies function by releasing a broad spectrum of bioactive molecules—including cytokines, growth factors, and extracellular vesicles—that act on multiple cell types within the host environment (Galipeau & Sensébé, 2018). This paracrine signaling modulates the local immune response, reduces inflammation, and stimulates endogenous tissue repair mechanisms (Vizoso et al., 2017). Because the therapeutic efficacy results from integrated signaling across numerous pathways and tissue levels, it is categorized as having pleiotropic targets rather than a specific molecular receptor or enzyme. This designation is common in pharmacological databases for advanced therapy medicinal products (ATMPs) where the mechanism of action is inherently multi-faceted and context-dependent (Pittenger et al., 2019).

Other names

Mesenchymal stem cell secretome targetsParacrine signaling factorsPleiotropic secreted factorsTissue-level paracrine targets

Paracrine modulation of the tissue microenvironment through the secretion of a complex mixture of cytokines, growth factors, and extracellular vesicles.